首页> 外文期刊>Nature reviews. Nephrology >ACUTE KIDNEY INJURY Clinical trials in AKI: is the end in sight?
【24h】

ACUTE KIDNEY INJURY Clinical trials in AKI: is the end in sight?

机译:急性肾损伤AKI的临床试验:即将结束吗?

获取原文
获取原文并翻译 | 示例
       

摘要

Clinical trials in patients with acute kidney injury (AKI) have been stymied by a lack of consensus on suitable renal-specific end points. In a recent analysis, Grams et al. suggest that a sustained 30-40% reduction in estimated glomerular filtration rate after hospital discharge might be a suitable intermediate end point for AKI clinical trials.
机译:急性肾损伤(AKI)患者的临床试验因对合适的肾脏特异性终点缺乏共识而受阻。在最近的分析中,Grams等人。提示出院后肾小球滤过率估计持续降低30-40%可能是AKI临床试验的合适中间终点。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号